You searched for side effects - Page 29 of 311 - Medivizor
Navigation Menu

Evaluating the effectiveness and safety of zanubrutinib versus ibrutinib in patients with Waldenström Macroglobulinemia.

Evaluating the effectiveness and safety of zanubrutinib versus ibrutinib in patients with Waldenström Macroglobulinemia.

Posted by on Feb 28, 2023 in Non-Hodgkin lymphoma | 0 comments

In a nutshell This study evaluated the effectiveness and safety of zanubrutinib (Brukinsa) versus ibrutinib (Imbruvica) in patients with Waldenström Macroglobulinemia (WM). The data showed that zanubrutinib had higher long-term response rates and lower side effects than ibrutinib in these patients. Some background WM is a type of cancer in which...

Read More

Evaluating the effectiveness of lenalidomide-containing triplet regimens in patients with first relapsed multiple myeloma.

Evaluating the effectiveness of lenalidomide-containing triplet regimens in patients with first relapsed multiple myeloma.

Posted by on Feb 28, 2023 in Multiple Myeloma | 0 comments

In a nutshell This study evaluated the effectiveness of lenalidomide (Revlimid)-containing regimens in patients with first relapsed multiple myeloma (MM). The data showed that daratumumab (Darzalex) combined with lenalidomide and dexamethasone (Rd) regimen significantly increased the survival without cancer worsening with fewer serious side effects...

Read More

Evaluating the effectiveness of acupuncture for the treatment of anxiety in patients with Parkinson’s disease.

Evaluating the effectiveness of acupuncture for the treatment of anxiety in patients with Parkinson’s disease.

Posted by on Feb 28, 2023 in Parkinson's Disease | 0 comments

In a nutshell This study evaluated the effectiveness of acupuncture for the treatment of anxiety in patients with Parkinson’s disease (PD). The data showed that acupuncture was an effective treatment for anxiety and improved the well-being of these patients. Some background Parkinson's disease (PD) is a disorder in which part of the brain is...

Read More

Evaluating the effectiveness and safety of gilteritinib plus azacitidine versus azacitidine alone for patients with newly diagnosed FLT3-mutated acute myeloid leukemia.

Evaluating the effectiveness and safety of gilteritinib plus azacitidine versus azacitidine alone for patients with newly diagnosed FLT3-mutated acute myeloid leukemia.

Posted by on Feb 28, 2023 in Leukemia | 0 comments

In a nutshell This study investigated the effectiveness and safety of gilteritinib (Xospata) plus azacitidine (Vidaza) versus azacitidine alone for patients with newly diagnosed FMS-like tyrosine kinase 3 (FLT3)-mutated acute myeloid leukemia (AML) who are unfit for intensive chemotherapy. The data showed that gilteritinib plus azacitidine...

Read More

Comparing the effectiveness and safety between immune checkpoint inhibitors and docetaxel in patients with non-small cell lung cancer.

Comparing the effectiveness and safety between immune checkpoint inhibitors and docetaxel in patients with non-small cell lung cancer.

Posted by on Feb 27, 2023 in Lung cancer | 0 comments

In a nutshell This study compared the effectiveness and safety between immune checkpoint inhibitors (ICIs) and docetaxel (Taxotere) therapy alone in patients with non-small cell lung cancer (NSCLC). The data showed ICIs significantly improved the survival outcomes with fewer serious side effects compared to docetaxel alone for the treatment of patients...

Read More

Comparing the effectiveness and safety of intralesional verapamil and collagenase Clostridium histolyticum injections in men with Peyronie’s disease.

Comparing the effectiveness and safety of intralesional verapamil and collagenase Clostridium histolyticum injections in men with Peyronie’s disease.

Posted by on Feb 27, 2023 in Erectile dysfunction | 0 comments

In a nutshell This study compared the effectiveness and safety of intralesional verapamil (Calan; ILV) and collagenase Clostridium histolyticum (Xiaflex; CCH) injections in men with Peyronie’s disease (PD). The data showed that CCH therapy was more effective than ILV, with a higher high level of patient satisfaction rate in the short term...

Read More

Evaluating the effectiveness and safety of noninvasive cerebellar stimulation in improving the balance and walking function of patients with stroke.

Evaluating the effectiveness and safety of noninvasive cerebellar stimulation in improving the balance and walking function of patients with stroke.

Posted by on Feb 27, 2023 in Stroke | 0 comments

In a nutshell This study evaluated the effectiveness and safety of noninvasive cerebellar stimulation (NICS) in improving the balance and walking function of patients with stroke. The data showed that NICS improved the balance and walking function in these patients. Some background A stroke is caused by a reduction in blood flow to the...

Read More

Evaluating the effectiveness of water therapeutic exercise in breast cancer survivors

Evaluating the effectiveness of water therapeutic exercise in breast cancer survivors

Posted by on Feb 19, 2023 in Breast cancer | 0 comments

In a nutshell The study evaluated the effectiveness of aquatic therapeutic exercise in breast cancer survivors for improving symptoms and quality of life. The study found that aquatic therapeutic exercise effectively improved fatigue, pain, and quality of life in these patients. Some background Breast cancer (BC) is the most common...

Read More

Safety and effectiveness of two different doses of daily-administered ABX464 in patients with unresponsive rheumatoid arthritis.

Safety and effectiveness of two different doses of daily-administered ABX464 in patients with unresponsive rheumatoid arthritis.

Posted by on Feb 5, 2023 in Rheumatoid Arthritis | 0 comments

In a nutshell This study investigated the safety and effectiveness of ABX464 (Obefazimod) in patients with active rheumatoid arthritis (RA) with inadequate responses to methotrexate (Trexall) or anti-tumor necrosis factor alpha (anti-TNFα) treatment. The authors concluded that ABX464 was safe and well-tolerated with promising effectiveness in these...

Read More

Evaluating the effectiveness and safety of replacing lenalidomide with pomalidomide for the treatment of patients with multiple myeloma who are unresponsive to a lenalidomide-containing combination regimen.

Evaluating the effectiveness and safety of replacing lenalidomide with pomalidomide for the treatment of patients with multiple myeloma who are unresponsive to a lenalidomide-containing combination regimen.

Posted by on Feb 5, 2023 in Multiple Myeloma | 0 comments

In a nutshell This study evaluated the effectiveness and safety of replacing lenalidomide (Revlimid) with pomalidomide (Pomalyst) for the treatment of patients with relapsed or refractory (r/r) multiple myeloma (MM) who were unresponsive to a lenalidomide-containing combination regimen. The data showed that pomalidomide was a safe and effective...

Read More

Evaluating the effectiveness and safety of penpulimab in patients with relapsed or refractory classical Hodgkin lymphoma.

Evaluating the effectiveness and safety of penpulimab in patients with relapsed or refractory classical Hodgkin lymphoma.

Posted by on Feb 5, 2023 in Hodgkin's lymphoma | 0 comments

In a nutshell This study evaluated the effectiveness and safety of penpulimab (AK105) for the treatment of patients with relapsed or refractory (r/r) classical Hodgkin lymphoma (cHL). The data showed that penpulimab was effective and safe with manageable side effects in these patients. Some background Classical Hodgkin lymphoma (cHL) is a cancer of...

Read More